Instil Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Instil Bio and other ETFs, options, and stocks.About TIL
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
CEOBronson Crouch
CEOBronson Crouch
Employees14
Employees14
HeadquartersDallas, Texas
HeadquartersDallas, Texas
Founded2018
Founded2018
Employees14
Employees14
TIL Key Statistics
Market cap74.67M
Market cap74.67M
Price-Earnings ratio-0.97
Price-Earnings ratio-0.97
Dividend yield—
Dividend yield—
Average volume60.03K
Average volume60.03K
High today$11.10
High today$11.10
Low today$10.32
Low today$10.32
Open price$10.41
Open price$10.41
Volume95.59K
Volume95.59K
52 Week high$42.79
52 Week high$42.79
52 Week low$10.17
52 Week low$10.17
Stock Snapshot
Instil Bio(TIL) stock is priced at $10.80, giving the company a market capitalization of 74.67M. It carries a P/E multiple of -0.97.
As of 2026-01-01, Instil Bio(TIL) stock has fluctuated between $10.32 and $11.10. The current price stands at $10.80, placing the stock +4.7% above today's low and -2.7% off the high.
The Instil Bio(TIL)'s current trading volume is 95.59K, compared to an average daily volume of 60.03K.
During the past year, Instil Bio(TIL) stock moved between $10.17 at its lowest and $42.79 at its peak.
During the past year, Instil Bio(TIL) stock moved between $10.17 at its lowest and $42.79 at its peak.
People also own
Based on the portfolios of people who own TIL. This list is generated using Robinhood data, and it’s not a recommendation.